| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Recursion Pharmaceuticals, Inc. (RXRX) have been net sellers, shedding 157,408 shares worth roughly $644K on balance. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
All 2 insiders who sold still hold shares after their sales. RXRX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.11M | $29.56M | -50,000 | |
| CEO | 2.07M | $7.29M | - | |
| Dir | 1.48M | - | - | |
| CFO | 1.07M | $3.65M | - | |
| Other | 1.04M | $3.30M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Borgeson Blake69 | Director | Sell10b5-1 | 30,000 | $3.68 | $110,400.00 | -0.5% | -5.8% | - | |
| May 22, 2026 | Gibson Christopher70 | Director | Sell10b5-1 | 40,000 | $3.08 | $123,200.00 | -4.3% | +11.0% | - | |
| May 7, 2026 | Gibson Christopher70 | Director | Sell10b5-1 | 40,000 | $3.37 | $134,800.00 | -4.1% | -3.1% | - | |
| May 5, 2026 | Borgeson Blake69 | Director | Sell10b5-1 | 30,000 | $3.52 | $105,600.00 | -0.5% | -5.6% | - | |
| Apr 22, 2026 | Gibson Christopher70 | Director | Sell10b5-1 | 40,000 | $3.61 | $144,400.00 | -4.2% | -17.4% | - | |
| Apr 7, 2026 | Gibson Christopher70 | Director | Sell10b5-1 | 40,000 | $3.10 | $124,000.00 | -4.2% | +24.1% | - | |
| Apr 7, 2026 | Borgeson Blake69 | Director | Sell10b5-1 | 30,000 | $3.10 | $93,000.00 | -0.5% | +24.1% | - | |
| Mar 23, 2026 | Gibson Christopher70 | Director | Sell10b5-1 | 40,000 | $3.25 | $130,000.00 | -4.2% | -1.5% | - | |
| Mar 17, 2026 | Taylor Ben R | Chief Financial Officer | Sell10b5-1 | 7,956 | $3.39 | $26,970.84 | -0.7% | -3.8% | - | |
| Mar 9, 2026 | Khan Najat49 | CEO and President | Sell10b5-1 | 28,298 | $3.35 | $94,659.64 | -1.2% | -5.4% | - |